Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Autoimmune Disorders

  Free Subscription


Articles published in J Nephrol

Retrieve available abstracts of 63 articles:
HTML format



Single Articles


    July 2025
  1. HIRANO K, Ikenoue T, Seki T, Komukai S, et al
    Development and validation of personalized risk prediction models for patients with IgA nephropathy: a nationwide multicenter cohort study.
    J Nephrol. 2025 Jul 11. doi: 10.1007/s40620-025-02338.
    PubMed     Abstract available


    June 2025
  2. DECAESTECKER A, Daniel A, Malbranque Z, Wayolle N, et al
    Crescentic glomerulonephritis associated with myelodysplatic syndrome and visceral leishmaniasis.
    J Nephrol. 2025 Jun 19. doi: 10.1007/s40620-025-02329.
    PubMed     Abstract available


  3. GOGGINS E, DeLaat A, Barr B, Taliercio J, et al
    Clinical uptake of an antigen-based approach to membranous nephropathy: a survey of general nephrologists and glomerular disease experts.
    J Nephrol. 2025 Jun 11. doi: 10.1007/s40620-025-02313.
    PubMed     Abstract available


    May 2025
  4. ISHIGAKI S, Takei H, Hiramoto K, Kaneko Y, et al
    Plasma cell-rich interstitial nephritis without glomerulonephritis in granulomatosis with polyangiitis.
    J Nephrol. 2025 May 30. doi: 10.1007/s40620-025-02318.
    PubMed    


    April 2025
  5. MATHEW GG
    Molecular markers or clinical end points? What is the optimal monitoring tool for low-dose rituximab in membranous nephropathy in resource-limited settings?
    J Nephrol. 2025 Apr 7. doi: 10.1007/s40620-025-02273.
    PubMed     Abstract available


  6. TANG C, Si FL, Chen P, Hou WY, et al
    Effectiveness and safety of finerenone in non-diabetic patients with IgA nephropathy.
    J Nephrol. 2025 Apr 1. doi: 10.1007/s40620-025-02240.
    PubMed    


    March 2025
  7. XU L, Wu C, Li G
    Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review.
    J Nephrol. 2025 Mar 26. doi: 10.1007/s40620-025-02261.
    PubMed     Abstract available


  8. CLAUDIO P, Gabriella M
    Targeting autophagy in autoimmune glomerular diseases.
    J Nephrol. 2025 Mar 19. doi: 10.1007/s40620-025-02267.
    PubMed     Abstract available


  9. MAHMOUD NB, Sahtout W, Ghabi F, Salem MB, et al
    Prognostic value of C3-exclusive deposits in post-infectious glomerulonephritis in adults: an observational cohort in Tunisia.
    J Nephrol. 2025 Mar 7. doi: 10.1007/s40620-025-02262.
    PubMed    


  10. BONELLI GD, Sciascia S, Calatroni M, L'imperio V, et al
    Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort.
    J Nephrol. 2025;38:643-653.
    PubMed     Abstract available


  11. EISINGER F, Neumann M, Worn M, Fritsche A, et al
    Comparison of GFR estimation in patients with diabetes mellitus using the EKFC and CKD-EPI equations.
    J Nephrol. 2025;38:707-716.
    PubMed     Abstract available


    February 2025
  12. SRIDHARAN K, Gopal B, Wilson S, Pham A, et al
    Obinutuzumab in Rituximab-resistant and recurrent membranous nephropathy: a case-series.
    J Nephrol. 2025 Feb 20. doi: 10.1007/s40620-025-02224.
    PubMed     Abstract available


  13. UMEZAWA Y, Aoki R, Ichikawa D, Suzuki Y, et al
    Glomerular galactose-deficient IgA1 and apoptosis inhibitor of macrophage staining in secondary IgA nephropathy associated with alcoholic cirrhosis.
    J Nephrol. 2025 Feb 13. doi: 10.1007/s40620-025-02213.
    PubMed     Abstract available


    January 2025
  14. KANG D, Zhang M, Chen Z, Zheng Z, et al
    Clinicopathological characteristics and prognosis of lupus nephritis patients with positive anti-ribonucleoprotein antibodies.
    J Nephrol. 2025 Jan 20. doi: 10.1007/s40620-024-02177.
    PubMed     Abstract available


    December 2024
  15. JAFRY NH, Butt N, Mubarak M, Akhtar SF, et al
    Anti-glomerular basement membrane disease complicated by malaria during pregnancy with successful maternal and fetal outcomes: a case report.
    J Nephrol. 2024;37:2655-2660.
    PubMed     Abstract available


    November 2024
  16. YANG M, Liu X, Chen Y, Chen X, et al
    Validation and modification of renal risk score for prediction of long-term kidney survival in patients with MPO-ANCA-associated glomerulonephritis.
    J Nephrol. 2024 Nov 22. doi: 10.1007/s40620-024-02134.
    PubMed     Abstract available


  17. KANBAY M, Ozbek L, Guldan M, Copur S, et al
    Post-transplant IgA nephropathy: a rapidly evolving field of kidney transplant medicine.
    J Nephrol. 2024 Nov 20. doi: 10.1007/s40620-024-02149.
    PubMed     Abstract available


  18. QUEYREL-MORANNE V, Daniel L, Moranne O
    Focal segmental glomerulosclerosis in a native African patient with systemic lupus erythematosus.
    J Nephrol. 2024 Nov 12. doi: 10.1007/s40620-024-02106.
    PubMed    


    October 2024
  19. ELAHI T, Ahmed S, Ahmed E, Mubarak M, et al
    Clinicopathological characteristics and outcomes of adult patients with idiopathic membranoproliferative glomerulonephritis according to an immunofluorescence-based classification.
    J Nephrol. 2024 Oct 14. doi: 10.1007/s40620-024-02083.
    PubMed     Abstract available


  20. ZHANG Q, Zhou F, Zhao Y, Luo C, et al
    The uncertain correlation of ANCAs in patients with lupus nephritis and crescents, an experience from Chinese centers.
    J Nephrol. 2024 Oct 10. doi: 10.1007/s40620-024-02085.
    PubMed     Abstract available


  21. BARAGETTI I, Del Vecchio L, Ferrario F, Alberici F, et al
    The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort.
    J Nephrol. 2024 Oct 6. doi: 10.1007/s40620-024-02071.
    PubMed     Abstract available


  22. HERNANDEZ-ANDRADE A, Nordmann-Gomes A, Juarez-Cuevas B, Zavala-Miranda MF, et al
    Urine epidermal growth factor as a biomarker for kidney function recovery and prognosis in glomerulonephritis with severe kidney function impairment.
    J Nephrol. 2024 Oct 4. doi: 10.1007/s40620-024-02068.
    PubMed     Abstract available


    July 2024
  23. YANG T, Shi Y, Wang Y, Feng Y, et al
    Hydroxychloroquine blood concentrations and effects in Chinese patients with IgA nephropathy.
    J Nephrol. 2024 Jul 24. doi: 10.1007/s40620-024-02029.
    PubMed     Abstract available


  24. BALTU D, Serin O, Aksu T, Hizarcioglu Gulsen H, et al
    Membranoproliferative glomerulonephritis in a patient with lysinuric protein intolerance: lesson for the clinical nephrologist.
    J Nephrol. 2024 Jul 17. doi: 10.1007/s40620-024-02018.
    PubMed    


  25. PERNA A, Campise M, Alfieri CM, Regalia A, et al
    Kidney transplantation in patients with ANCA-associated vasculitis is associated with a high incidence of post-transplant cancer.
    J Nephrol. 2024;37:1611-1619.
    PubMed     Abstract available


    June 2024
  26. SARA M, Anna S, Lorenzo B, Valentina B, et al
    Macrophage activation syndrome secondary to systemic lupus erythematosus: lesson for the clinical nephrologist.
    J Nephrol. 2024 Jun 28. doi: 10.1007/s40620-024-01997.
    PubMed    


  27. RATNAYAKE C, Crombie T, Fraenkel M, McMahon LP, et al
    Haemoptysis in a stable kidney transplant patient previously seropositive for anti-GBM and ANCA glomerulonephritis.
    J Nephrol. 2024 Jun 18. doi: 10.1007/s40620-024-01993.
    PubMed    


  28. LIM RS, Yeo SC
    EXternal validation of international IgA nephropathy prediction tool in a Singapore CohorT (EXIST Study).
    J Nephrol. 2024 Jun 13. doi: 10.1007/s40620-024-01985.
    PubMed    


  29. LIU L, de Leeuw K, der Meer BD, van Goor H, et al
    Expression of myxovirus resistance protein A in lupus nephritis and other glomerular nephropathies.
    J Nephrol. 2024 Jun 5. doi: 10.1007/s40620-024-01971.
    PubMed    


  30. CUGNO M, Mancuso MC, Depetri F, Peyvandi F, et al
    IgM autoantibodies to complement factor H in C3 glomerulopathy.
    J Nephrol. 2024 Jun 1. doi: 10.1007/s40620-024-01961.
    PubMed    


    May 2024
  31. NAGARAJAH S, Saleh QW, Rasmussen M, Tepel M, et al
    Long non-coding RNA MGAT3 in kidney transplant recipients with immunoglobulin A nephropathy.
    J Nephrol. 2024;37:1133-1135.
    PubMed    


  32. CETINKAYA H, Gursu M, Yazici H, Cebeci E, et al
    Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy?
    J Nephrol. 2024;37:923-932.
    PubMed     Abstract available


    April 2024
  33. DAVIES E, Chetwynd A, McDowell G, Rao A, et al
    The current use of proteomics and metabolomics in glomerulonephritis: a systematic literature review.
    J Nephrol. 2024 Apr 30. doi: 10.1007/s40620-024-01923.
    PubMed     Abstract available


  34. SHAHEEN M, Bharat A, Friedman AN, Guo S, et al
    ALECT2 amyloidosis with concurrent IgG4-related interstitial nephritis, membranous nephropathy and diabetic kidney disease: a case report and literature review.
    J Nephrol. 2024 Apr 17. doi: 10.1007/s40620-024-01924.
    PubMed     Abstract available


    March 2024
  35. ROBERT JT, Rajaram A, Fiset PO, Bernard C, et al
    Class V lupus nephritis recurrence with histologic resolution in a kidney transplant recipient on a pregnancy-adapted immunosuppression protocol: a lesson for the clinical nephrologist.
    J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-024-01920.
    PubMed    


  36. HU D, Wang Z, Wang S, Li Y, et al
    Lymphatic vessels in patients with crescentic glomerulonephritis: association with renal pathology and prognosis.
    J Nephrol. 2024 Mar 25. doi: 10.1007/s40620-024-01903.
    PubMed     Abstract available


  37. REN W, Sun J, Zhang L, He W, et al
    Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01893.
    PubMed     Abstract available


  38. ARNAERT S, Schepens N, Deleu L, Malfait T, et al
    Case report: renal recovery in Goodpasture's syndrome treated with rituximab.
    J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-024-01892.
    PubMed     Abstract available


  39. VAZ DE CASTRO PAS, Amaral AA, Almeida MG, Selvaskandan H, et al
    Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis.
    J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-023-01874.
    PubMed     Abstract available


    February 2024
  40. CHRISTODOULOU M, Moysidou E, Lioulios G, Stai S, et al
    The prognostic value of two histopathologic classification models of ANCA-associated glomerulonephritis: a prospective study.
    J Nephrol. 2024 Feb 12. doi: 10.1007/s40620-023-01855.
    PubMed     Abstract available


  41. OCHIAI S, Kikuchi M, Kaikita K, Fujimoto S, et al
    Rapidly progressive glomerulonephritis due to IgA nephropathy accompanied by collagenofibrotic glomerulopathy. A nephrology picture.
    J Nephrol. 2024 Feb 6. doi: 10.1007/s40620-023-01875.
    PubMed    


    January 2024
  42. TRIMARCHI H, Fervenza FC, Coppo R
    Points of view in nephrology: personalized management of IgA nephropathy, beyond KDIGO.
    J Nephrol. 2024 Jan 18. doi: 10.1007/s40620-023-01833.
    PubMed     Abstract available


  43. HE WJ, Wang J, Liu N, Li GY, et al
    The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience.
    J Nephrol. 2024 Jan 16. doi: 10.1007/s40620-023-01839.
    PubMed     Abstract available


    December 2023
  44. SCHENA FP, Cox SN
    Correction to: Is it time for personalized therapy in IgA nephropathy patients?
    J Nephrol. 2023 Dec 8. doi: 10.1007/s40620-023-01861.
    PubMed    


  45. BOUSSETTA A, Jellouli M, Hajji M, Rekaya S, et al
    A membranous nephropathy in a 5 year-old boy: and if that's not all? A nephrology quiz.
    J Nephrol. 2023 Dec 6. doi: 10.1007/s40620-023-01821.
    PubMed    


    November 2023
  46. ALBERTAZZI V, Fontana F, Giberti S, Aiello V, et al
    Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-up.
    J Nephrol. 2023 Nov 13. doi: 10.1007/s40620-023-01803.
    PubMed     Abstract available


  47. BANJONGJIT A, Thammathiwat T, Townamchai N, Kanjanabuch T, et al
    SARS-CoV-2 infection associated with antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (ANCA-GN): a systematic review and two case reports.
    J Nephrol. 2023 Nov 6. doi: 10.1007/s40620-023-01777.
    PubMed     Abstract available


  48. RUSSWURM M, Kortus-Goetze B, Maier-Giebing T, Groene HJ, et al
    General prognostic models may neglect vulnerable subgroups in ANCA-associated vasculitis.
    J Nephrol. 2023;36:2269-2280.
    PubMed     Abstract available


  49. GOTO K, Imaizumi T, Hamada R, Ishikura K, et al
    Renal pathology in adult and paediatric population of Japan: review of the Japan renal biopsy registry database from 2007 to 2017.
    J Nephrol. 2023;36:2257-2267.
    PubMed     Abstract available


  50. XIONG L, Liu L, Tao Y, Guo H, et al
    Clinical significance of IgM and C3 deposition in children with primary immunoglobulin A nephropathy.
    J Nephrol. 2023;36:2213-2222.
    PubMed     Abstract available


  51. RAO IR, Kolakemar A, Shenoy SV, Prabhu RA, et al
    Hydroxychloroquine in nephrology: current status and future directions.
    J Nephrol. 2023;36:2191-2208.
    PubMed     Abstract available


  52. SCURT FG, Hirschfeld V, Ganz M, Mertens PR, et al
    Low levels of complement factor C3 at diagnosis can predict outcome in antineutrophil antibody associated vasculitis.
    J Nephrol. 2023;36:2281-2293.
    PubMed     Abstract available


  53. WANG F, Jin Y, Zhou F, Luo L, et al
    Urinary isomorphic red blood cells for the prediction of disease severity and renal outcomes in MPO-ANCA-associated vasculitis: a retrospective cohort study.
    J Nephrol. 2023;36:2295-2304.
    PubMed     Abstract available


  54. ROCCATELLO D, Careddu A, Ferro M, Naretto C, et al
    The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy.
    J Nephrol. 2023;36:2223-2231.
    PubMed     Abstract available


  55. ALVAREZ L, Kambham N, Su R
    Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan.
    J Nephrol. 2023;36:2365-2370.
    PubMed     Abstract available


    October 2023
  56. LIU Z, Wan C, Cao Y, Liu S, et al
    Distribution spectrum and clinical significance of glomerular exostosin (EXT1) deposits in PLA2R-positive membranous nephropathy.
    J Nephrol. 2023 Oct 26. doi: 10.1007/s40620-023-01779.
    PubMed     Abstract available


  57. PALA C, Parenti E, Vizzini G, Gianfreda D, et al
    Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful treatment with eculizumab.
    J Nephrol. 2023 Oct 17. doi: 10.1007/s40620-023-01789.
    PubMed     Abstract available


  58. MONGERA N, Passler W, Sethi S, Kozakowski N, et al
    A case of protocadherin FAT1-positive membranous nephropathy secondary to hematopoietic stem-cell transplantation.
    J Nephrol. 2023 Oct 10. doi: 10.1007/s40620-023-01786.
    PubMed    


    September 2023
  59. PAOLO SF, Natasha CS
    Is it time for personalized therapy in IgA nephropathy patients?
    J Nephrol. 2023 Sep 22. doi: 10.1007/s40620-023-01745.
    PubMed    


  60. AI S, Yan X, Zhao X, Ye W, et al
    Malignancy-associated membranous nephropathy: focus on diagnosis and treatment.
    J Nephrol. 2023 Sep 15. doi: 10.1007/s40620-023-01751.
    PubMed     Abstract available


  61. BAIER E, Kluge IA, Hakroush S, Tampe B, et al
    Low hemoglobin levels are associated with Bowman's capsule rupture and peritubular capillaritis in ANCA-associated renal vasculitis: a link of vascular injury to anemia?
    J Nephrol. 2023 Sep 7. doi: 10.1007/s40620-023-01748.
    PubMed     Abstract available


  62. DIRIM AB, Agargun BF, Hurdogan O, Ozluk Y, et al
    Two cases of IgA nephropathy after splenectomy: spleen as a silent culprit in the pathogenesis of IgA nephropathy.
    J Nephrol. 2023 Sep 4. doi: 10.1007/s40620-023-01764.
    PubMed    


    June 2023
  63. WATANABE H, Yamana H, Okada A, Matsui H, et al
    Therapeutic plasma exchange for anti-glomerular basement membrane disease with dialysis-dependent kidney failure without diffuse alveolar hemorrhage.
    J Nephrol. 2023 Jun 24. doi: 10.1007/s40620-023-01695.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.